Study Uses Genetic Testing to Personalize Treatment for Deadly Blood Cancer

“A clinical trial using genetic testing to match acute myeloid leukemia (AML) patients with new therapies is now open at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC). The center is one of seven cancer centers nationwide participating in the Beat AML® Master Trial, sponsored by the Leukemia & Lymphoma Society (LLS).” More details are here: http://www.umm.edu/programs/cancer/about-us/news/2017/beat-aml-master-trial

Share:

Author: lw

Leave a Reply

Your email address will not be published. Required fields are marked *